European stroke prevention study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke;European stroke prevention study 2: Dipyridamol und azetylsalizylsaure zur sekundarpravention des schlaganfalls

Nervenheilkunde

Volumn 18, Issue 7, 1999, Pages 380-390

  Diener, H ^a   Cunha, L ^a   Forbes, C ^a   Sivenius, J ^a   Smets, P ^a   Lowenthal, A ^a  

^a NONE

Author keywords

Acetylsalicylic acid; Dipyridamole; Secondary prevention; Stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE;

ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; STROKE;

EID: 0032694114     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alheid U, Reichwehr I, Foerstermann U. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP. Eur J Pharmacol 1989; 164: 103-10.
2. American-Canadian Co-operative Study Group. Persantin aspirin trial in cerebral ischemia. Part II: Endpoint results. Stroke 1983; 16: 406-15.
3. Anti-platelet Trialists Collaboration. Secondary prevention of vascular diseases by prolonged anti-platelet treatment. Br Med J 1988; 296: 320-31.
4. Anti-platelet Trialists Collaboration. Collaborative overview of randomized trials of anti-platelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients. Br Med J 1994a; 308: 81-106.
5. Anti-platelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. II: Maintenance of vascular graft or arterial patency by anti-platelet therapy. Br Med J 1994b; 308: 159-68.
6. Anti-platelet Trialists Collaboration. Collaborative overwiew of randomized trials of anti-platelet therapy. III: Reduction in venous thrombosis and pulmonary embolism by anti-platelet prophylaxis among surgical and medical patients. Br Med J 1994c; 308: 235-46.
7. Bertrand-Hardy JM, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: Baseline data. J Neurol Sci 1995; 131 (Suppl.): 1-58.
8. Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-4.
9. Bousser MG, Eschwege E, Hagenah M, et al. »AICLA« controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983; 14: 5-14.
10. EAFT Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993; 342: 1255-62.
11. ESPS Group. The European Stroke Prevention Study (ESPS): Principal endpoints. Lancet 1987; ii: 1351-4.
12. ESPS Group. European Stroke Prevention Study. Stroke 1990; 21: 1122-30.
13. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-16.
14. Gent M, Easton JD, Hachinski VC, et al. and the CATS Group. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1889; ii: 1215-20.
15. Hass WK, Easton JD, Adams Jr HP, et al. the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-7.
16. Miller RG. Survival Analysis, New York: J Wiley and Sons 1981.
17. Müller TH, Su CAPF, Weisenberger H, et al. Dipyridamole alone or combined with low-dose acetylsalicylic acide inhibits platelet aggregation in human hole blood ex vivo. Br J Clin Pharmac 1990; 30: 179-86.
18. Patrono C, Roth GJ. Aspirin in ischaemic cerebrovascular disease. How strong is the case for a different dosing regimen? Stroke 1996; 27: 756-60.
19. Pocock J. Clinical Trials. Chichester: J Wiley and Sons 1983.
20. SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338: 1345-9.
21. UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-54.
22. Van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-7.